منابع مشابه
Prostate-Specific Antigen (PSA) Test
• Prostate-specific antigen (PSA) is a protein produced by cells of the prostate gland. The PSA test measures the level of PSA in the blood (see Question 1). • The U.S. Food and Drug Administration (FDA) has approved the use of the PSA test along with a digital rectal exam to help detect prostate cancer in men age 50 and older. The FDA has also approved the PSA test to monitor patients with a h...
متن کاملThe Significance of Oxytocin in Canine Mammary Tumours Betydelsen av oxytocin vid juvertumörer hos hund
.................................................................................................................................................. 1 Sammanfattning ...................................................................................................................................... 2 Introduction ......................................................................................
متن کاملWhat to do with an abnormal PSA test.
For more than a decade, prostate-specific antigen (PSA) has been used for prostate cancer screening. Over the years, this screening has been continually refined, including investigation into the use of lower total PSA thresholds, PSA isoforms, and PSA kinetics. This review describes the evolution of prostate cancer screening and provides clinical insights into the informed use of PSA and its ad...
متن کاملYinglu Guo: PSA screening test requires wider application in China
www.amepc.org/tau © Translational Andrology and Urology. All rights reserved. Prof. Yinglu Guo (Figure 1), MD, is an academician of Chinese Academy of Engineering, academic leader of Urology and Andrology. He is the honorary president of Peking University First Hospital and honorary director of Institute of Urology, Peking University; Dean of Peking University Urologist Training College and And...
متن کاملIs an improved PSA screening test in sight?
A fter decades of searching for a replacement for prostate-specific antigen (PSA) in prostate cancer screening, many researchers are once again examining variations on the long-beleaguered biomarker. PSA has withstood years of skepticism from critics who blame it for the overdiag-nosis and overtreatment of millions of men since it became the favorite prostate cancer screening test in the early ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Tidsskrift for Den norske legeforening
سال: 2013
ISSN: 0029-2001
DOI: 10.4045/tidsskr.13.0809